Rockefeller Capital Management’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
SFM
BH
AC
VCM
RA
WCM
BAM
Rockefeller Capital Management's ANGO Position: Q1 2026 in Review
Rockefeller Capital Management increased its AngioDynamics (ANGO) stake by 398% in Q1 2026, buying an estimated $5.74K and bringing the position to 663 shares worth $7.54K. The position accounts for ﹤0.01% of the portfolio, ranked #4110.
Rockefeller Capital Management first reported a position in ANGO in Q2 2022 and has held it in 5 quarters since. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.
- Rockefeller Capital Management held 663 shares of AngioDynamics worth $7.54K as of Q1 2026.
- Rockefeller Capital Management bought 530 AngioDynamics shares in Q1 2026, an estimated $5.74K.
- AngioDynamics made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #4110 holding.
- Rockefeller Capital Management first reported a position in AngioDynamics in Q2 2022 and has held it in 5 quarters since.
- 147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.
Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.